Cellular and molecular mechanisms involved in the establishment of HIV-1 latency

Por Donahue, Daniel A, Wainberg, Mark A
Publicado em 2013

SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A

Por Donahue, Daniel A., Porrot, Françoise, Couespel, Norbert, Schwartz, Olivier
Publicado no J Virol (2017)

The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency

Por Donahue, Daniel A., Kuhl, Björn D., Sloan, Richard D., Wainberg, Mark A.
Publicado em 2012

Latent HIV-1 Can Be Reactivated by Cellular Superinfection in a Tat-Dependent Manner, Which Can Lead to the Emergence of Multidrug-Resistant Recombinant Viruses

Por Donahue, Daniel A., Bastarache, Sophie M., Sloan, Richard D., Wainberg, Mark A.
Publicado em 2013

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency

Por Bastarache, Sophie M., Mesplède, Thibault, Donahue, Daniel A., Sloan, Richard D., Wainberg, Mark A.
Publicado em 2014

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes

Por Sloan, Richard D, Donahue, Daniel A, Kuhl, Björn D, Bar-Magen, Tamara, Wainberg, Mark A
Publicado em 2010

Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

Por Sloan, Richard D., Kuhl, Björn D., Mesplède, Thibault, Münch, Jan, Donahue, Daniel A., Wainberg, Mark A.
Publicado em 2013

Tetherin restricts direct cell-to-cell infection of HIV-1

Por Kuhl, Björn D, Sloan, Richard D, Donahue, Daniel A, Bar-Magen, Tamara, Liang, Chen, Wainberg, Mark A
Publicado em 2010

Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef

Por Sloan, Richard D., Kuhl, Björn D., Donahue, Daniel A., Roland, André, Bar-Magen, Tamara, Wainberg, Mark A.
Publicado em 2011

Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture

Por Donahue, Daniel A., Sloan, Richard D., Kuhl, Björn D., Bar-Magen, Tamara, Schader, Susan M., Wainberg, Mark A.
Publicado em 2010

The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism

Por Kuhl, Björn D., Cheng, Vicky, Donahue, Daniel A., Sloan, Richard D., Liang, Chen, Wilkinson, John, Wainberg, Mark A.
Publicado em 2011

SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV

Por Donahue, Daniel A., Amraoui, Sonia, di Nunzio, Francesca, Kieffer, Camille, Porrot, Françoise, Opp, Silvana, Diaz-Griffero, Felipe, Casartelli, Nicoletta, Schwartz, Olivier
Publicado no J Virol (2016)

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes

Por Bar-Magen, Tamara, Sloan, Richard D, Faltenbacher, Verena H, Donahue, Daniel A, Kuhl, Björn D, Oliveira, Maureen, Xu, Hongtao, Wainberg, Mark A
Publicado em 2009

Identification of Novel Mutations Responsible for Resistance to MK-2048, a Second-Generation HIV-1 Integrase Inhibitor

Por Bar-Magen, Tamara, Sloan, Richard D., Donahue, Daniel A., Kuhl, Björn D., Zabeida, Alexandra, Xu, Hongtao, Oliveira, Maureen, Hazuda, Daria J., Wainberg, Mark A.
Publicado em 2010

Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load

Por Kramer, Victor G., Schader, Susan M., Oliveira, Maureen, Colby-Germinario, Susan P., Donahue, Daniel A., Singhroy, Diane N., Tressler, Randy, Sloan, Richard D., Wainberg, Mark A.
Publicado em 2012